Publikationen von M. Ebinger

Ebinger, M.; Sievers, C.; Klotsche, J.; Schneider, H. J.; Leonards, C. O.; Pieper, L.; Wittchen, H.-U.; Stalla, G. K.; Endres, M.: Triglycerides and stroke risk prediction: lessons from a prospective cohort study in german primary care patients. Frontiers in Neurology 1, doi:10.3389/fneur.2010.00148 (2010)

Ebinger, M.; Sievers, C.; Ivan, D.; Schneider, H. J.; Stalla, G. K.: Is there a neuroendocrinological rationale for testosterone as a therapeutic option in depression? Journal of Psychopharmacology 23 (7), S. 841 - 853 (2009)

Rosenhagen, M. C.; Schmidt, U.; Ebinger, M.; Nickel, T.; Uhr, M.: Successful treatment of chronic fatigue syndrome with duloxetine and trijodthyronine - A case study. Journal of Clinical Psychopharmacology 28 (1), S. 105 - 107 (2008)

Uhr, M.; Tontsch, A.; Namendorf, C.; Ripke, S.; Lucae, S.; Ising, M.; Dose, T.; Ebinger, M.; Rosenhagen, M.; Kohli, M. et al.; Kloiber, S.; Salyakina, D.; Bettecken, T.; Specht, M.; Pütz, B.; Binder, E. B.; Müller-Myhsok, B.; Holsboer, F.: Polymorphisms in the drug transporter Gene ABCB1 predict antidepressant treatment response in depression. Neuron 57, S. 203 - 209 (2008)

Ebinger, M.; Behl, C.; Rosenhagen, M.; Uhr, M.: P-glycoprotein has negligible effects on estradiol and testosterone in mice. Neuroscience Letters 427 (1), S. 6 - 9 (2007)

Uhr, M.; Grauer, M. T.; Yassouridis, A.; Ebinger, M.: Blood-brain barrier penetration and pharmacokinetics of amitriptyline and its metabolites in p-glycoprotein (abcb1ab) knock-out mice and controls. Journal of Psychiatric Research 41 (1-2), S. 179 - 188 (2007)

Ebinger, M.; Uhr, M.: ABC drug transporter at the blood-brain barrier. Effects on drug metabolism and drug response. European Archives of Psychiatry and Clinical Neuroscience 256, S. 294 - 298 (2006)

Rosenhagen, M. C.; Schmidt, U.; Winkelmann, J.; Ebinger, M.; Knetsch, I.; Weber, F.: Olanzapine-induced oculogyric crisis. Journal of Clinical Psychopharmacology 26 (4), S. 431 - 431 (2006)

Ebinger, M.; Uhr, M.: Is testosterone a substrate of P-glycoprotein in abcb1ab knock out mice? Pharmacopsychiatry 38 (5), S. 238 - 238 (2005)

Ebinger, M.; Grauer, M. T.; Uhr, M.: Intrathecal IgA synthesis in neurosyphilis. Journal of the Neurological Sciences 228 (1), S. 21 - 25 (2005)

Uhr, M.; Ebinger, M.; Rosenhagen, M. C.; Grauer, M. T.: The anti-Parkinson drug budipine is exported actively out of the brain by P-glycoprotein in mice. Neuroscience Letters 383, S. 73 - 76 (2005)

Uhr, M.; Namendorf, C.; Grauer, M. T.; Rosenhagen, M.; Ebinger, M.: P-glycoprotein is a factor in the uptake of dextromethorphan, but not of melperone, into the mouse brain: evidence for an overlap in substrate specificity between P-gp and CYP2D6. Journal of Psychopharmacology 18 (4), S. 509 - 515 (2004)

Ebinger, M.; Grauer, M. T.; Weiser, C.; Rickel, S.; Franc, D.; Uhr, M.: Results of routine CSF analysis of 1000 psychiatric patients. Pharmacopsychiatry 36 (5), S. 222 - 222 (2003)

Grauer, M. T.; Namendorf, C.; Ebinger, M.; Rippel, A.; Uhr, M.: Lipidperoxidation of brain homogenate and the non-enzymatic antioxidants vitamin C and vitamin E in abcb1ab (-/-) mutants and FVB controls. Pharmacopsychiatry 36 (5), S. 228 - 229 (2003)

Ebinger, M.: Neurophänomenologie: Ein Oxymoron als Lückenfüller. Die Transformation der Phänomenologie durch Francisco J. Varela - eine Deformation? Dissertation, Julius-Maximilians-Universität, Würzburg (2005)